Patrick E. H. Jackson

Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19

Russell G. Jones, T. Braciale, C. Krawczyk, 2023, Science Immunology.

Rev-Rev Response Element Activity Selection Bias at the HIV Transmission Bottleneck

D. Rekosh, M. Hammarskjold, Jordan Holsey, 2023, bioRxiv.

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial

W. Petri, R. Dewar, H. Haughey, 2022, Open forum infectious diseases.

Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial

H. Haughey, U. Nayak, J. Sturek, 2023, medRxiv.

Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial

J. Allen, Uma Nayak, Jennifer Hendrick, 2024, Open Forum Infectious Diseases.